These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35470744)

  • 1. A review of IL-36: an emerging therapeutic target for inflammatory dermatoses.
    Hwang J; Rick J; Hsiao J; Shi VY
    J Dermatolog Treat; 2022 Sep; 33(6):2711-2722. PubMed ID: 35470744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications.
    Iznardo H; Puig L
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting dysbiosis in psoriasis, atopic dermatitis, and hidradenitis suppurativa: the gut-skin axis and microbiome-directed therapy.
    Aguwa C; Enwereji N; Santiago S; Hine A; Kels GG; McGee J; Lu J
    Clin Dermatol; 2023; 41(5):640-649. PubMed ID: 37816413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions.
    Sachen KL; Arnold Greving CN; Towne JE
    Cytokine; 2022 Aug; 156():155897. PubMed ID: 35679693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting IL-36 in Inflammatory Skin Diseases.
    Fukaura R; Akiyama M
    BioDrugs; 2023 May; 37(3):279-293. PubMed ID: 36867370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic Analysis of Hidradenitis Suppurativa: A Unique Molecular Signature with Broad Immune Activation.
    Ben Abdallah H; Bregnhøj A; Iversen L; Johansen C
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.
    Campione E; Lanna C; Diluvio L; Cannizzaro MV; Grelli S; Galluzzo M; Talamonti M; Annicchiarico-Petruzzelli M; Mancini M; Melino G; Candi E; Schiavone G; Wang Y; Shi Y; Bianchi L
    Cell Cycle; 2020 Feb; 19(3):257-267. PubMed ID: 31905036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases.
    Ahmad F; Alam MA; Ansari AW; Jochebeth A; Leo R; Al-Abdulla MN; Al-Khawaga S; AlHammadi A; Al-Malki A; Al Naama K; Ahmad A; Buddenkotte J; Steinhoff M
    J Invest Dermatol; 2024 Feb; 144(2):206-224. PubMed ID: 38189700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
    Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG
    J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived stress in four inflammatory skin diseases: an analysis of data taken from 7273 adult subjects with acne, atopic dermatitis, psoriasis or hidradenitis suppurativa.
    Misery L; Chesnais M; Merhand S; Aubert R; Bru MF; Legrand C; Raynal H; Taieb C; Richard MA
    J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):e623-e626. PubMed ID: 35181931
    [No Abstract]   [Full Text] [Related]  

  • 11. IL-36 cytokines are increased in acne and hidradenitis suppurativa.
    Di Caprio R; Balato A; Caiazzo G; Lembo S; Raimondo A; Fabbrocini G; Monfrecola G
    Arch Dermatol Res; 2017 Oct; 309(8):673-678. PubMed ID: 28852851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Potential of IL-1 Antagonism in Hidradenitis Suppurativa.
    Calabrese L; Malvaso D; Coscarella G; Antonelli F; D'Amore A; Gori N; Rubegni P; Peris K; Chiricozzi A
    Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of psychiatric comorbidities in psoriasis, hidradenitis suppurativa and atopic dermatitis: The importance of a psychodermatological approach.
    Iannone M; Janowska A; Panduri S; Morganti R; Davini G; Romanelli M; Dini V
    Exp Dermatol; 2022 Jun; 31(6):956-961. PubMed ID: 35285091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Essential Role of microRNAs in Inflammatory and Autoimmune Skin Diseases-A Review.
    Dopytalska K; Czaplicka A; Szymańska E; Walecka I
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.
    Fletcher JM; Moran B; Petrasca A; Smith CM
    Clin Exp Immunol; 2020 Aug; 201(2):121-134. PubMed ID: 32379344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa.
    Thomi R; Yerly D; Yawalkar N; Simon D; Schlapbach C; Hunger RE
    Br J Dermatol; 2017 Nov; 177(5):1358-1366. PubMed ID: 28301691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New treatment of pyoderma gangrenosum and hidradenitis suppurativa: A review.
    Yamanaka K
    J Dermatol; 2024 Feb; 51(2):172-179. PubMed ID: 38009911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn's disease.
    Berman HS; Villa NM; Shi VY; Hsiao JL
    J Dermatolog Treat; 2021 Mar; 32(2):261-263. PubMed ID: 31389737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-standing refractory hidradenitis suppurativa responded to a brodalumab monotherapy in a patient with psoriasis: A possible involvement of Th17 across the spectrum of both diseases.
    Yoshida Y; Oyama N; Iino S; Shimizu C; Hasegawa M
    J Dermatol; 2021 Jun; 48(6):916-920. PubMed ID: 33609416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What's New in Dermatological Therapy?].
    Bachelez H
    Ann Dermatol Venereol; 2015 Dec; 142 Suppl 3():S49-54. PubMed ID: 26792414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.